CASI Pharmaceuticals Inc. (CASI) Is Up Sharply On Manufacturing Deal
CASI Pharmaceuticals Inc. (CASI) announced Thursday morning that it has entered into a strategic and long-term manufacturing agreement with Yiling Wanzhou International Pharmaceutical for entecavir and cilostazol.
Source: RTTNews